Efficacy of COVID-HIGIV in animal models of SARS-CoV-2 infection

In late 2019 the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus emerged in China and quickly spread into a worldwide pandemic. It has caused millions of hospitalizations and deaths, despite the use of COVID-19 vaccines. Convalescent plasma and monoclonal antibodies emerged as maj...

Descripción completa

Detalles Bibliográficos
Autores principales: Jha, Aruni, Barker, Douglas, Lew, Jocelyne, Manoharan, Vinoth, van Kessel, Jill, Haupt, Robert, Toth, Derek, Frieman, Matthew, Falzarano, Darryl, Kodihalli, Shantha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549041/
https://www.ncbi.nlm.nih.gov/pubmed/36216961
http://dx.doi.org/10.1038/s41598-022-21223-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549041/
https://www.ncbi.nlm.nih.gov/pubmed/36216961
http://dx.doi.org/10.1038/s41598-022-21223-2

Ejemplares similares